• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖相关非酒精性脂肪性肝病的新见解:多器官与肝脏之间失调的“串扰”?

New insight of obesity-associated NAFLD: Dysregulated "crosstalk" between multi-organ and the liver?

作者信息

Wang Ya-Di, Wu Liang-Liang, Qi Xiao-Yan, Wang Yuan-Yuan, Liao Zhe-Zhen, Liu Jiang-Hua, Xiao Xin-Hua

机构信息

Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.

出版信息

Genes Dis. 2022 Jan 28;10(3):799-812. doi: 10.1016/j.gendis.2021.12.013. eCollection 2023 May.

DOI:10.1016/j.gendis.2021.12.013
PMID:37396503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10308072/
Abstract

Obesity plays a crucial role in the development of non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanism for the pathogenesis of obesity-associated NAFLD remains largely obscure. Although the "multiple hit" theory provides a more accurate explanation of NAFLD pathogenesis, it still cannot fully explain precisely how obesity causes NAFLD. The liver is the key integrator of the body's energy needs, receiving input from multiple metabolically active organs. Thus, recent studies have advocated the "multiple crosstalk" hypothesis, highlighting that obesity-related hepatic steatosis may be the result of dysregulated "crosstalk" among multiple extra-hepatic organs and the liver in obesity. A wide variety of circulating endocrine hormones work together to orchestrate this "crosstalk". Of note, with deepening understanding of the endocrine system, the perception of hormones has gradually risen from the narrow sense (i.e. traditional hormones) to the broad sense of hormones as organokines and exosomes. In this review, we focus on the perspective of organic endocrine hormones (organokines) and molecular endocrine hormones (exosomes), summarizing systematically how the two types of new hormones mediate the dialogue between extra-hepatic organs and liver in the pathogenesis of obesity-related NAFLD.

摘要

肥胖在非酒精性脂肪性肝病(NAFLD)的发生发展中起关键作用。然而,肥胖相关NAFLD发病机制的潜在机制在很大程度上仍不清楚。尽管“多重打击”理论对NAFLD发病机制提供了更准确的解释,但它仍无法完全精确解释肥胖如何导致NAFLD。肝脏是身体能量需求的关键整合器,接收来自多个代谢活跃器官的输入。因此,最近的研究提出了“多重串扰”假说,强调肥胖相关的肝脂肪变性可能是肥胖状态下多个肝外器官与肝脏之间“串扰”失调的结果。多种循环内分泌激素共同作用来协调这种“串扰”。值得注意的是,随着对内分泌系统理解的深入,对激素的认知已逐渐从狭义(即传统激素)上升到广义的作为器官因子和外泌体的激素。在这篇综述中,我们聚焦于有机内分泌激素(器官因子)和分子内分泌激素(外泌体)的视角,系统总结这两类新激素在肥胖相关NAFLD发病机制中介导肝外器官与肝脏之间对话的方式。

相似文献

1
New insight of obesity-associated NAFLD: Dysregulated "crosstalk" between multi-organ and the liver?肥胖相关非酒精性脂肪性肝病的新见解:多器官与肝脏之间失调的“串扰”?
Genes Dis. 2022 Jan 28;10(3):799-812. doi: 10.1016/j.gendis.2021.12.013. eCollection 2023 May.
2
New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).深入探讨器官间串扰在非酒精性脂肪性肝病(NAFLD)发病机制中的作用。
Protein Cell. 2018 Feb;9(2):164-177. doi: 10.1007/s13238-017-0436-0. Epub 2017 Jun 22.
3
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma.器官因子在非酒精性脂肪性肝病/非酒精性脂肪性肝炎相关肝细胞癌发展中的作用。
J Cell Biochem. 2022 Oct;123(10):1553-1584. doi: 10.1002/jcb.30252. Epub 2022 Jul 12.
4
The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD).作为内分泌器官的胃:关键调节基因的表达及其对肥胖和非酒精性脂肪性肝病(NAFLD)的影响
Curr Gastroenterol Rep. 2018 Apr 19;20(6):24. doi: 10.1007/s11894-018-0629-6.
5
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)的多重打击发病机制。
Metabolism. 2016 Aug;65(8):1038-48. doi: 10.1016/j.metabol.2015.12.012. Epub 2016 Jan 4.
6
Organokines and Exosomes: Integrators of Adipose Tissue Macrophage Polarization and Recruitment in Obesity.器官因子和外泌体:肥胖中脂肪组织巨噬细胞极化和募集的整合者。
Front Endocrinol (Lausanne). 2022 Feb 18;13:839849. doi: 10.3389/fendo.2022.839849. eCollection 2022.
7
Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future.非酒精性脂肪性肝炎(NASH)与器官因子:现在与未来。
Int J Mol Sci. 2022 Jan 2;23(1):498. doi: 10.3390/ijms23010498.
8
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中脂肪组织胰岛素抵抗与肝巨噬细胞的串扰。
J Hepatol. 2019 Nov;71(5):1012-1021. doi: 10.1016/j.jhep.2019.06.031. Epub 2019 Jul 10.
9
Organokines in disease.器官运动因子与疾病
Adv Clin Chem. 2020;94:261-321. doi: 10.1016/bs.acc.2019.07.012. Epub 2019 Aug 12.
10
Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.肝脏脂质蓄积:血糖调节激素失调的原因及后果
J Endocrinol. 2017 Jul;234(1):R1-R21. doi: 10.1530/JOE-16-0513. Epub 2017 Apr 20.

引用本文的文献

1
Elevated miR-34a induced by lipotoxicity and inflammation mediates pathophysiological communication between hepatocytes and hepatic stellate cells in liver fibrosis.脂毒性和炎症诱导的miR-34a升高介导了肝纤维化中肝细胞与肝星状细胞之间的病理生理通讯。
Genes Dis. 2025 Apr 18;12(6):101648. doi: 10.1016/j.gendis.2025.101648. eCollection 2025 Nov.
2
The Role of miRNAs and Epigenetic Factors in Non-Alcoholic Fatty Liver Disease - a Systematic Review.微小RNA和表观遗传因素在非酒精性脂肪性肝病中的作用——一项系统综述
Curr Health Sci J. 2025 Jan-Mar;51(1):37-52. doi: 10.12865/CHSJ.51.01.04. Epub 2025 Mar 31.
3
Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?

本文引用的文献

1
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus.治疗非酒精性脂肪性肝病和 2 型糖尿病的新兴治疗方法。
Nat Rev Endocrinol. 2021 Aug;17(8):484-495. doi: 10.1038/s41574-021-00507-z. Epub 2021 Jun 15.
2
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
3
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.脂肪细胞因子、肌细胞因子和肝细胞因子:串扰和代谢后果。
2型糖尿病合并非酒精性脂肪性肝病患者使用吡格列酮联合SGLT2抑制剂或GLP-1受体激动剂:老朋友与新药物联合使用能否产生更好的疗效?
Arch Med Sci Atheroscler Dis. 2025 Mar 14;10:e1-e15. doi: 10.5114/amsad/202298. eCollection 2025.
4
Ginseng and its functional components in non-alcoholic fatty liver disease: therapeutic effects and multi-target pharmacological mechanisms.人参及其功能成分在非酒精性脂肪性肝病中的治疗作用及多靶点药理机制
Front Pharmacol. 2025 Apr 9;16:1540255. doi: 10.3389/fphar.2025.1540255. eCollection 2025.
5
Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).所选食品添加剂对肠道微生物群及代谢功能障碍相关脂肪性肝病(MASLD)的影响
Medicina (Kaunas). 2025 Jan 22;61(2):192. doi: 10.3390/medicina61020192.
6
A Novel "Endocrine Hormone": The Diverse Role of Extracellular Vesicles in Multiorgan Insulin Resistance.一种新型“内分泌激素”:细胞外囊泡在多器官胰岛素抵抗中的多样作用。
Int J Med Sci. 2024 Aug 6;21(11):2081-2093. doi: 10.7150/ijms.97217. eCollection 2024.
7
Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation.黄连-虎杖药对通过 NF-κB/NLRP3 通路改善小鼠非酒精性脂肪性肝病:网络药理学、分子对接和实验验证。
Hereditas. 2024 Apr 3;161(1):12. doi: 10.1186/s41065-024-00316-0.
8
Glutamine prevents high-fat diet-induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress.谷氨酰胺通过调节脂肪分解和氧化应激来预防高脂饮食诱导的小鼠肝脏脂质积累。
Nutr Metab (Lond). 2024 Mar 8;21(1):12. doi: 10.1186/s12986-024-00784-1.
9
A sport supplement candidate of Erigeron breviscapus extract regulates lipogenesis in vitro and in vivo.灯盏花提取物作为一种运动补剂候选物在体外和体内调节脂肪生成。
Phys Act Nutr. 2023 Dec;27(4):60-66. doi: 10.20463/pan.2023.0039. Epub 2023 Dec 31.
10
Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease.全面策略鉴定细胞外囊泡表面蛋白作为非酒精性脂肪肝病生物标志物。
Int J Mol Sci. 2023 Aug 28;24(17):13326. doi: 10.3390/ijms241713326.
Int J Mol Sci. 2021 Mar 5;22(5):2639. doi: 10.3390/ijms22052639.
4
Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR-29 family.胰腺 β 细胞通过分泌外泌体 miR-29 家族来控制葡萄糖稳态。
J Extracell Vesicles. 2021 Jan;10(3):e12055. doi: 10.1002/jev2.12055. Epub 2021 Jan 21.
5
MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice.M2 极化巨噬细胞来源的外泌体 miRNA-690 可改善肥胖小鼠的胰岛素敏感性。
Cell Metab. 2021 Apr 6;33(4):781-790.e5. doi: 10.1016/j.cmet.2020.12.019. Epub 2021 Jan 14.
6
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance.高脂肪饮食诱导的外泌体磷脂酰胆碱上调导致胰岛素抵抗。
Nat Commun. 2021 Jan 11;12(1):213. doi: 10.1038/s41467-020-20500-w.
7
ER stress-induced adipocytes secrete-aldo-keto reductase 1B7-containing exosomes that cause nonalcoholic steatohepatitis in mice.内质网应激诱导的脂肪细胞分泌含有醛酮还原酶 1B7 的细胞外体,导致小鼠非酒精性脂肪性肝炎。
Free Radic Biol Med. 2021 Feb 1;163:220-233. doi: 10.1016/j.freeradbiomed.2020.12.011. Epub 2020 Dec 25.
8
Osteocalcin and Non-Alcoholic Fatty Liver Disease: Lessons From Two Population-Based Cohorts and Animal Models.骨钙素与非酒精性脂肪性肝病:来自两个基于人群的队列研究和动物模型的启示。
J Bone Miner Res. 2021 Apr;36(4):712-728. doi: 10.1002/jbmr.4227. Epub 2020 Dec 21.
9
A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo.高脂肪饮食可减弱脂肪细胞中 AMPKα1 的表达,从而诱导外泌体释放并促进非酒精性脂肪肝的发生发展。
Diabetes. 2021 Feb;70(2):577-588. doi: 10.2337/db20-0146. Epub 2020 Dec 1.
10
Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis.髓系细胞特异性 IL-6 信号促进富含 microRNA-223 的外泌体产生,从而减轻非酒精性脂肪性肝病相关纤维化。
Hepatology. 2021 Jul;74(1):116-132. doi: 10.1002/hep.31658. Epub 2021 Apr 27.